News Highlights: Top Company News of the Day
May 27 2020 - 3:30AM
Dow Jones News
Boeing to Start Voluntary Layoffs, Will Shed an Initial 2,500 Workers
Boeing will this week announce about 2,500 voluntary layoffs in
the first phase of broader cuts triggered by the coronavirus-driven
collapse of global air travel.
France's Macron Orders Up Billions in Aid for Auto Industry
The French government is taking steps to prop up France's auto
industry amid a collapse in car purchases caused by the coronavirus
crisis.
Sanofi to Offload Regeneron Stake
Sanofi will raise up to $11.7 billion by selling almost its
entire 20.6% stake in U.S. biotech Regeneron.
Infineon Raises EUR1B for Cypress Buy
Infineon said its has raised about EUR1.06 billion through a
share placement to partially fund its acquisition of Cypress
Semiconductor.
Merck Does Deals to Develop Coronavirus Vaccines, Drug
Drugmaker Merck said it is buying a privately held Austrian
company to obtain one vaccine while joining with other groups on a
second vaccine and an antiviral.
Boeing, Airbus Study Coronavirus on Flights
The airplane makers are researching the coronavirus's behavior
inside jetliners, part of the industry's effort to curb risks that
have brought air traffic to a near standstill.
Amazon in Advanced Talks to Buy Self-Driving-Car Tech Company Zoox
Amazon is in advanced talks to buy Zoox, a move that would
expand its reach in autonomous-vehicle technology, people familiar
with the matter say.
Amtrak Prepares to Cut 20% of Workforce
Amtrak is preparing to cut up to 20% of its workforce in the
next fiscal year as the national railroad continues to suffer from
a huge decline in ridership as the coronavirus pandemic brought
most travel to a halt.
SEC Fines Ares $1 Million for Compliance Failures
Ares Management has agreed to pay $1 million to settle
allegations that it bought stock in one of its portfolio companies
while an Ares employee sat on that company's board and had access
to inside information.
Biocon's CytoSorb Approved in India to Treat Critical Covid-19 Patients
CytoSorb will be used to reduce pro-inflammatory cytokines
levels in Covid-19 patients admitted to intensive care units who
have confirmed or imminent respiratory failure.
(END) Dow Jones Newswires
May 27, 2020 03:15 ET (07:15 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.